Christopher D. Thanos
48Patents
7h-index
39Co-inventors
65Inventor score
Filing activity: Apr 18, 2006 → Feb 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9682934B2 | Modified amino acids | Chemistry; Metallurgy | 24 | Active |
| US8778870B2 | Modified factor IX polypeptides and uses thereof | Human Necessities | 19 | Active |
| US9764039B2 | Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 18 | Active |
| US9988619B2 | Non-natural amino acid tRNA synthetases for pyridyl tetrazine | Chemistry; Metallurgy | 16 | Active |
| US9938516B2 | Non-natural amino acid tRNA synthetases for para-methylazido-L-phenylalanine | Chemistry; Metallurgy | 15 | Active |
| US8519103B2 | Factor VII polypeptides that are modified and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US10112900B2 | Modified amino acids | Chemistry; Metallurgy | 9 | Active |
| US10190145B2 | Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression | Chemistry; Metallurgy | 7 | Active |
| US9738724B2 | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 6 | Active |
| US9994527B2 | Modified amino acids | Chemistry; Metallurgy | 6 | Active |
| US9650621B2 | Proteolytic inactivation of select proteins in bacterial extracts for improved expression | Chemistry; Metallurgy | 5 | Active |
| US10774354B2 | Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression | Chemistry; Metallurgy | 5 | Active |
| US9795655B2 | Modified MT-SP1 proteases that inhibit complement activation | Chemistry; Metallurgy | 5 | Active |
| US11168326B2 | Engineered immunostimulatory bacterial strains and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US10450353B2 | Proteolytic inactivation of select proteins in bacterial extracts for improved expression | Chemistry; Metallurgy | 4 | Active |
| US10669347B2 | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 4 | Active |
| US9732161B2 | Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use | Chemistry; Metallurgy | 3 | Active |
| US10730837B2 | Modified amino acids | Chemistry; Metallurgy | 3 | Active |
| US11779612B2 | Engineered immunostimulatory bacterial strains and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US11261219B2 | Proteolytic inactivation of select proteins in bacterial extracts for improved expression | Chemistry; Metallurgy | 3 | Active |
| US11242528B2 | Engineered immunostimulatory bacterial strains and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10160961B2 | Factor VII polypeptides that are modified and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10179909B2 | Non-natural amino acid tRNA synthetases for pyridyl tetrazine | Chemistry; Metallurgy | 2 | Active |
| US9476037B2 | Factor VII polypeptides that are modified and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9328339B2 | Modified factor IX polypeptides and uses thereof | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.